Cambria Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Cambria Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-19,647	Closed	-$4.26M	–	240
2021 Q1	$4.26M	Buy	19,647 +5,841	+42%	+$1.1M	0.85%	23
2020 Q4	$1.59M	Buy	13,806 +2,655	+24%	+$297K	0.54%	35
2020 Q3	$1.09M	Buy	11,151 +2,124	+24%	+$244K	0.4%	47
2020 Q2	$1.11M	Buy	9,027 +531	+6%	+$60.2K	0.41%	42
2020 Q1	$744K	Buy	8,496 +1,062	+14%	+$112K	0.28%	56
2019 Q4	$777K	Buy	7,434 +3,951	+113%	+$443K	0.21%	145
2019 Q3	$401K	Buy	+3,483	New	+$529K	0.06%	205

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Cambria Investment Management's GWPH Position: Q2 2021 in Review

Cambria Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 19,647 shares — an estimated $4.26M sold.

Cambria Investment Management first reported a position in GWPH in Q3 2019 and held it in 7 quarters. The position peaked at $4.26M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Cambria Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Cambria Investment Management sold 19,647 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4.26M.
Cambria Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2019 and held it in 7 quarters.
Cambria Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4.26M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Cambria Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.